InsiderTrades

Form 4 for CBUS Cibus, Inc.

Accepted 2023-06-02 00:00:00 ET · period of report 2023-03-01 · accession 0001615594-23-000045 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-02 2023-05-31 CBUS Koschak William CFO A - Grant $0.00 +6,333 19.5K +48% $0
DM 2023-06-02 2023-03-01 CBUS Koschak William CFO D - Sale to Iss — -386.0K 0 -100% —
DM 2023-06-02 2023-03-01 CBUS Koschak William CFO A - Grant — +386.0K 26.0K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-31 A A 6,333 $0.00 19,506 D — — (F1) Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
2 Derivative Stock Option (Right-to-Buy) 2023-03-01 D D 250,000 — 0 D $1.27 · — to 2032-03-24 250,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
3 Derivative Stock Option (Right-to-Buy) 2023-03-01 A A 250,000 — 250,000 D $1.27 · — to 2032-03-24 250,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
4 Derivative Stock Option (Right-to-Buy) 2023-03-01 D D 26,000 — 0 D $8.05 · — to 2031-03-12 26,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
5 Derivative Stock Option (Right-to-Buy) 2023-03-01 A A 110,000 — 110,000 D $4.55 · — to 2030-08-04 110,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
6 Derivative Stock Option (Right-to-Buy) 2023-03-01 D D 110,000 — 0 D $4.55 · — to 2030-08-04 110,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
7 Derivative Stock Option (Right-to-Buy) 2023-03-01 A A 26,000 — 26,000 D $8.05 · — to 2031-03-12 26,000 Common Stock (F2) The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.